Effects of herbal Epimedium on the improvement of bone metabolic disorder through the induction of osteogenic differentiation from bone marrow-derived mesenchymal stem cells
Open Access
- 9 December 2016
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 15 (1) , 125-130
Abstract
Herbal Epimedium (HE) has been commonly used as a tonic, antirheumatic agent and in the treatment of bone‑associated diseases including osteoporosis. Treatment for osteoporosis is important to increase bone mass density and maintain to balance of bone remodeling. The present study was performed to investigate the effects of HE on mouse bone marrow mesenchymal stem cell (mBMMSC) proliferation and osteogenic differentiation, using MTT assays, proliferating cell nuclear antigen (PCNA) detection and apoptosis and differentiation assays. HE was demonstrated to inhibit the proliferation of mBMMSCs up to 45.43±3.33% and to decrease the level of PCNA expression compared with untreated cells. HE also induced late apoptosis at 24 and 48 h after treatment up to 71.93 and 67.03%, respectively, while only 14.93% of untreated cells exhibited apoptosis. By contrast, HE induced differentiation of mBMMSCs into an osteogenic lineage at the beginning of three weeks after commencement of treatment. This suggested that HE is a candidate as an inducer of osteogenesis from bone marrow mesenchymal stem cells, and additionally has potential for use in the treatment of bone metabolic disorders such as osteoporosis.Keywords
This publication has 21 references indexed in Scilit:
- Appropriate models for novel osteoporosis drug discovery and future perspectivesExpert Opinion on Drug Discovery, 2015
- Distinct Roles of Bcl-2 and Bcl-Xl in the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells during DifferentiationPLOS ONE, 2011
- Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised miceBritish Journal of Nutrition, 2010
- Herba Epimedii water extract elevates estrogen level and improves lipid metabolism in postmenopausal womenPhytotherapy Research, 2008
- Cell and gene therapy using mesenchymal stem cells (MSCs)Journal of Autoimmunity, 2008
- Adult bone marrow–derived stem cells for organ regeneration and repairDevelopmental Dynamics, 2007
- Cell therapy and the safety of embryonic stem cell-derived graftsTrends in Biotechnology, 2007
- OsteoporosisThe Lancet, 2006
- Aging of mesenchymal stem cell in vitroBMC Cell Biology, 2006
- The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppressionGene, 2004